Vikas Goyal Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Vikas Goyal.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Vikas Goyal. Vikas Goyal is Director in Morphic Holding, Inc. ($MORF) and Director in Spero Therapeutics, Inc. ($SPRO) and See Remarks in Pandion Therapeutics, Inc. ($PAND).
Latest Insider Trading Transactions of Vikas Goyal
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, MORF, PAND, SPRO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 01 2021 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Option Exercise | D | 17.75 | 73,789 | 1,309,755 | 0 | |
| Apr 01 2021 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Option Exercise | D | 18.00 | 28,227 | 508,086 | 0 | |
| Apr 01 2021 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Sell | U | 60.00 | 87,764 | 5,265,840 | 0 | 87.8 K to 0 (-100.00 %) |
| Mar 08 2021 | MORF | Morphic Holding, I ... | Goyal Vikas | Director | Buy | P | 70.00 | 1,000 | 70,000 | 1,000 | 0 to 1,000 |
| Feb 10 2021 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Option Exercise | A | 17.75 | 73,789 | 1,309,755 | 73,789 | |
| Jul 21 2020 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Option Exercise | C | 0.00 | 35,922 | 0 | 0 | |
| Jul 21 2020 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Option Exercise | A | 18.00 | 10,486 | 188,748 | 10,486 | |
| Jul 21 2020 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Option Exercise | A | 18.00 | 13,935 | 250,830 | 13,935 | |
| Jul 21 2020 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Option Exercise | A | 18.00 | 3,806 | 68,508 | 3,806 | |
| Jul 21 2020 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Buy | P | 18.00 | 1,450 | 26,100 | 87,764 | 86.3 K to 87.8 K (+1.68 %) |
| Jul 21 2020 | PAND | Pandion Therapeuti ... | Goyal Vikas | See Remarks | Buy | C | 0.00 | 7,044 | 0 | 86,314 | 79.3 K to 86.3 K (+8.89 %) |
| Jun 19 2020 | MORF | Morphic Holding, I ... | Goyal Vikas | Director | Option Exercise | A | 22.96 | 12,000 | 275,520 | 12,000 | |
| Aug 02 2019 | MORF | Morphic Holding, I ... | Goyal Vikas | Director | Option Exercise | A | 22.80 | 24,000 | 547,200 | 24,000 | |
| Jul 01 2019 | MORF | Morphic Holding, I ... | Goyal Vikas | Director | Option Exercise | C | 0.00 | 830,489 | 0 | 0 | |
| Jul 01 2019 | MORF | Morphic Holding, I ... | Goyal Vikas | Director | Option Exercise | C | 0.00 | 1,469,950 | 0 | 0 | |
| Jul 01 2019 | MORF | Morphic Holding, I ... | Goyal Vikas | Director | Buy | P | 15.00 | 333,333 | 4,999,995 | 2,633,772 | 2.3 M to 2.6 M (+14.49 %) |
| Jul 01 2019 | MORF | Morphic Holding, I ... | Goyal Vikas | Director | Buy | C | 0.00 | 830,489 | 0 | 2,300,439 | 1.5 M to 2.3 M (+56.50 %) |
| Jul 01 2019 | MORF | Morphic Holding, I ... | Goyal Vikas | Director | Buy | C | 0.00 | 1,469,950 | 0 | 1,469,950 | 0 to 1.5 M |
| Nov 07 2017 | SPRO | Spero Therapeutics ... | Goyal Vikas | Director | Option Exercise | C | 0.00 | 3,683,045 | 0 | 0 | |
| Nov 07 2017 | SPRO | Spero Therapeutics ... | Goyal Vikas | Director | Option Exercise | C | 0.00 | 1,250,000 | 0 | 0 | |
| Nov 07 2017 | SPRO | Spero Therapeutics ... | Goyal Vikas | Director | Option Exercise | C | 0.00 | 982,906 | 0 | 0 | |
| Nov 07 2017 | SPRO | Spero Therapeutics ... | Goyal Vikas | Director | Option Exercise | C | 0.00 | 1,483,784 | 0 | 0 | |
| Nov 07 2017 | SPRO | Spero Therapeutics ... | Goyal Vikas | Director | Buy | P | 14.00 | 428,571 | 5,999,994 | 1,854,006 | 1.4 M to 1.9 M (+30.07 %) |
| Nov 07 2017 | SPRO | Spero Therapeutics ... | Goyal Vikas | Director | Buy | C | 0.00 | 606,024 | 0 | 1,425,435 | 819.4 K to 1.4 M (+73.96 %) |
| Nov 07 2017 | SPRO | Spero Therapeutics ... | Goyal Vikas | Director | Buy | C | 0.00 | 328,992 | 0 | 819,411 | 490.4 K to 819.4 K (+67.08 %) |
| Nov 07 2017 | SPRO | Spero Therapeutics ... | Goyal Vikas | Director | Buy | C | 0.00 | 246,272 | 0 | 490,419 | 244.1 K to 490.4 K (+100.87 %) |
| Nov 07 2017 | SPRO | Spero Therapeutics ... | Goyal Vikas | Director | Buy | C | 0.00 | 244,147 | 0 | 244,147 | 0 to 244.1 K |
Page: 1